MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Internal tremor in Parkinson disease and essential tremor: a new glance at a common symptom

    A. Fonseca, M. Lima, C. Duque, V. Carvalho, M. Calejo (Matosinhos, Portugal)

    Objective: To assess the prevalence of internal tremor in a cohort of PD versus ET patients and its association with non-motor symptoms. Background: Internal tremor…
  • 2023 International Congress

    What do people with parkinsonism consider important and want to achieve?

    K. Lloyd, E. Tenison, Y. Ben-Shlomo, E. Henderson (Bristol, United Kingdom)

    Objective: To describe pilot data from goal setting interviews in people with Parkinsonism to understand what they consider important and want to achieve. Background: Parkinson’s…
  • 2023 International Congress

    Huntington disease-like: an atypical presentation of Niemann-Pick type C.

    MB. Charra Castellani, V. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)

    Objective: Report a case of adult-onset Niemann-Pick disease type C (NPC) with Huntington disease-like (HDL) phenotype. Background: NPC is a neurodegenerative autosomal recessive lysosomal storage…
  • 2023 International Congress

    The Quebec Parkinson Network (QPN): Interdisciplinary Collaboration in Parkinson’s Disease and Related Disorders Research.

    M. Blais, S. Bogard, C. Degroot, N. Dupré, E. Fon (Quebec City, Canada)

    Objective: By creating a participant registry, gathering information on participants, and ensuring appropriate data exchange with research groups, the QPN's primary goal is to increase…
  • 2023 International Congress

    Evidence of Central Autonomic Network dysfunction in orthostatic hypotension of Parkinson’s disease

    L. Xavier, E. Dayan, N. Browner, M. Sklerov (Carrboro, USA)

    Objective: To examine the contribution of the central autonomic network (CAN) to physiologic evidence of autonomic failure in Parkinson’s disease (PD). Background: Autonomic dysfunction, particularly…
  • 2023 International Congress

    Movement disorders in children with progressive myoclonic epilepsies

    M. Ben Hafsa, H. Benrhouma, M. Jamoussi, T. Ben Younes, Z. Miladi, A. Zioudi, H. Klaa, I. Kraoua, I. Ben Youssef-Turki (Tunis, Tunisia)

    Objective: To analyze the clinical aspects, radiological features and evolution of myoclonus and other movement disorders (MD) in children with progressive myoclonic epilepsies (PMEs). Background:…
  • 2023 International Congress

    Epigenetic clocks suggest accelerated ageing in isolated REM Sleep Behavior Disorder patients

    L. Baldelli, C. Pirazzini, L. Sambati, F. Ravaioli, D. Gentilini, G. Calandra-Buonaura, P. Guaraldi, C. Franceschi, P. Cortelli, P. Garagnani, MG. Bacalini, F. Provini (Bologna, Italy)

    Objective: To investigate biological aging in videopolysomnography (vPSG)-confirmed isolated REM Sleep Behavior Disorder (iRBD) patients and vPSG-negative controls, using DNA methylation-based epigenetic clocks. Background: Isolated…
  • 2023 International Congress

    Rapidly progressive dementia – catatonia – myoclonus in 80 years old patient: An unusual case

    DAN. Rebolledo Garcia, ART. Cadena Fernandez, ANA. Michel Chavez, JUA. Calderon Martinez, HOR. Senties Madrid, GRI. Romero Sanchez (Mexico City, Mexico)

    Objective: Objective:Sporadic Creutzfeldt-Jakob Disease (sCJD) will be challenging to differentiate from other diseases, like NMDA autoimmune encephalitis (AE). The classic rapidly progressive dementia phenotype that…
  • 2023 International Congress

    Benefit of multiple incobotulinumtoxinA injections for pain reduction in adults with cervical dystonia: an analysis of pooled data

    A. Albanese, J. Wissel, W. Jost, A. Castagna, M. Althaus, G. Comes, A. Scheschonka, M. Vacchelli, H. Jinnah (Rozzano, Italy)

    Objective: To assess the long-term effects of repeated incobotulinumtoxinA (inco-A) injections on cervical dystonia (CD)-related pain in a pooled analysis of studies in adults with…
  • 2023 International Congress

    Pediatric Myoclonus-Dystonia misdiagnosed as CASPR2 encephalitis – a diagnostic challenge

    L. Dias, R. Pissarra, J. Fonseca, C. Melo, M. Sampaio, R. Sousa (Porto, Portugal)

    Objective: Describe the clinical/laboratory challenges in diagnosis of myoclonus-dystonia at a young age Background: SGCE Myoclonus-Dystonia (SGCE-M-D) is a genetic movement disorder characterized by multifocal…
  • « Previous Page
  • 1
  • …
  • 455
  • 456
  • 457
  • 458
  • 459
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley